Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

SIRONA 2 Trial Heart Failure NYHA Class III

NCT: NCT04012944 · ACTIVE_NOT_RECRUITING

NCT IDNCT04012944
StatusACTIVE_NOT_RECRUITING
Start Date2019-06-26
SponsorEndotronix, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, multi-center, open-label, single-arm CE-Mark trial to assess device safety and efficacy of the Cordella PA Sensor System in up to 75 New York Heart Association (NYHA) Class III Heart Failure patients who will receive the Cordella PA Sensor Implant.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑